Press Release/October 23, 2017
Artoss, Inc. is pleased to announce NanoBone QD Bone Graft.
Paul Byerley, Managing Director of Artoss, Inc., the exclusive North American distributors for NanoBone in orthopaedic surgery, said, “To extend the usability of NanoBone, we put the perfect handling of NanoBone SBX Putty in an applicator designed for QD – quick delivery. This easy-to-use device facilitates rapid implantation of our advanced bone graft in a controlled and precise manner. Artoss developed NanoBone QD to provide these benefits in a cost-effective delivery system.”
Walter Gerike, Managing Director of Artoss GmbH said, “Nanotechnology is the key technology for the 21st century and Artoss is harnessing this potential for orthopaedic surgery. With the launch of NanoBone SBX Putty in 2016, we created a product that combines Applied NanoBiology™ for bone repair with perfect handling for the surgeon. NanoBone QD takes the product one step further by making it easier for the surgeon to implant.” NanoBone synthetic bone graft products have been used in Europe and the US for more than ten years in approaching 400,000 clinical cases across all indications and has been available in the United States since 2015.
Artoss, Inc. is launching NanoBone QD at the North American Spine Society Meeting this week. Visit them at Booth 1562 to learn more.
For further information, please contact:
15900 155th St. NE
Foley, MN 56329